World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
Novartis drug development 2010-2015
11/12/2010
Grouped Articles
Novartis Starts $5 Billion Share Buyback
Wall Street Journal 11.22.2013
Novartis Replaces Top Management in Japan
Wall Street Journal 04.04.2014
Wall Street Journal 11.12.2010
Novartis's MS Drug Gets Approval from EU
Wall Street Journal 03.21.2011
How Novartis Plans to Avoid the 'Patent Cliff'
BusinessWeek 08.04.2011
Wall Street Journal 09.13.2011
Wall Street Journal 12.08.2011
Novartis Drug Goes Under Safety Review
Wall Street Journal 12.23.2011
EU Regulator Reviews Novartis MS Pill
Wall Street Journal 01.23.2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03.06.2012
U.K. Backs Novartis Multiple Sclerosis Pill
Wall Street Journal 03.16.2012
Novartis and Penn Unite On Anticancer Approach
New York Times 08.06.2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
